author-photo

Hidekazu Kuramochi

University of Southern California

109

Papers

1317

Citations

Citation Trend

Filter By

Papers (87) Sort By

Journal Conference Others

Phase II Study of Neoadjuvant Chemotherapy With S-1 Plus Oxaliplatin for Gastric Cancer Clinical T4 or N2-3

2021
Show All
- Source
- Cite
- Save
Citations (0)
The Pre-treatment Lymphocyte-to-Monocyte Ratio Predicts Efficacy in Metastatic Colorectal Cancer Treated With TAS-102 and Bevacizumab.

2021 Anticancer Research
Show All
- Source
- Cite
- Save
Citations (2)
The pretreatment lymphocyte-to-monocyte ratio (LMR) to predict treatment efficacy and prognosis in metastatic colorectal cancer treated with the combination of TAS-102 and bevacizumab (TAS-CC3 Study).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
RAS Mutations in Circulating Tumor DNA and Clinical Outcomes of Rechallenge Treatment With Anti-EGFR Antibodies in Patients With Metastatic Colorectal Cancer

2020
Show All
- Source
- Cite
- Save
Citations (7)
RAS status in circulating-tumor DNA (ctDNA) and outcomes during rechallenge treatments with anti-EGFR antibodies in metastatic colorectal cancer (mCRC).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
FOLFIRINOX for Recurrent Pancreatic Cancer After Pancreatic Resection: A Secondary Analysis of the Nationwide Multicenter Observational Study Conducted by the Japan Adjuvant Study Group of Pancreatic Cancer 06.

2020 Pancreas
Show All
- Source
- Cite
- Save
Citations (0)
The combination of TAS-102 and bevacizumab as the third-line chemotherapy for metastatic colorectal cancer (TAS-CC3 Study).

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
P-114Relationship between peripheral neuropathy and effectiveness in second-line chemotherapy for unresectable advanced gastric cancer: a prospective, observational, multicenter study protocol

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
SAPPHIRE: a randomised phase II study of planned discontinuation or continuous treatment of oxaliplatin after six cycles of modified FOLFOX6 plus panitumumab in patients with colorectal cancer

2019 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (8)
Amphiregulin/epiregulin mRNA Expression and Primary Tumor Location in Colorectal Cancer

2019 Anticancer Research
Show All
- Source
- Cite
- Save
Citations (2)